| Pharmaceutical active ingredients: |
| Peginterferon Alfa-2b rbe |
| Available forms, composition and doses of Intron A Peg: |
| N / A |
| Intron A Peg medical category: |
| Human:InterferonsNucleosides and nucleotides |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L03AB10 - Peginterferon Alfa-2b |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Schering-Plough |
| Related documents and information about Intron A Peg: |
| Intron A prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Pegtron | Peginterferon Alfa-2b | Schering-Plough |
| Sylatron | Peginterferon Alfa-2b | Bayer Schering Pharma |
| Unitron Peg | Peginterferon Alfa-2b | Merck; Bayer Schering Pharma; Schering-Plough |
| Viraferon Peg | Peginterferon Alfa-2b | Schering-Plough |
| ViraferonPeg | Peginterferon Alfa-2b | Schering-Plough; Fulford Pharmaceuticals; Pfizer |
| Pegatron | Peginterferon Alfa-2b; Ribavirin | Schering-Plough |
| Pegatron Combination Therapy | Peginterferon Alfa-2b; Ribavirin | Schering-Plough |
| Pegetron | Peginterferon Alfa-2b; Ribavirin | Merck; Bayer Schering Pharma; Schering-Plough |
| Pegintron / Rebetol Combo Pack | Peginterferon Alfa-2b; Ribavirin | Schering-Plough; Bayer Schering Pharma |
| Pegtron Cotronak Kit | Peginterferon Alfa-2b; Ribavirin | Schering-Plough |